Page last updated: 2024-08-23

mifepristone and Diffuse Mixed Small and Large Cell Lymphoma

mifepristone has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giefing, M; Jin, J; Klapper, W; Krams, M; Krause, K; Ma, L; Siebert, R; Sotnikova, A; Szczepanowski, M; Xu, G1

Other Studies

1 other study(ies) available for mifepristone and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma.
    British journal of haematology, 2007, Volume: 139, Issue:2

    Topics: Apoptosis; Cell Line, Tumor; Flow Cytometry; Gene Expression Regulation; Guanine Nucleotide Dissociation Inhibitors; Hodgkin Disease; Humans; Immunohistochemistry; Lymphoma, Non-Hodgkin; Mifepristone; Reed-Sternberg Cells; Reverse Transcriptase Polymerase Chain Reaction; rho Guanine Nucleotide Dissociation Inhibitor alpha; rho Guanine Nucleotide Dissociation Inhibitor beta; rho-Specific Guanine Nucleotide Dissociation Inhibitors; Transfection; Transgenes; Tumor Suppressor Proteins

2007